Evaluation of Daratumumab for the Treatment of Multiple Myeloma in Patients with High-risk Cytogenetic Factors: A Systematic Review and Meta-analysis

  1. Giri, S.
  2. Grimshaw, A.
  3. Bal, S.
  4. Godby, K.
  5. Kharel, P.
  6. Djulbegovic, B.
  7. Dimopoulos, M.A.
  8. Facon, T.
  9. Usmani, S.Z.
  10. Mateos, M.-V.
  11. Costa, L.J.
Zeitschrift:
JAMA Oncology

ISSN: 2374-2445 2374-2437

Datum der Publikation: 2020

Ausgabe: 6

Nummer: 11

Seiten: 1759-1765

Art: Rezension

DOI: 10.1001/JAMAONCOL.2020.4338 GOOGLE SCHOLAR